94 related articles for article (PubMed ID: 6398284)
1. Mechanism of action of nickel as a carcinogen: needed information.
Furst A
IARC Sci Publ; 1984; (53):245-52. PubMed ID: 6398284
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical and biological attributes of nickel compounds in relationship to carcinogenic activities.
Sunderman FW
J UOEH; 1987 Mar; 9 Suppl():84-94. PubMed ID: 3602750
[TBL] [Abstract][Full Text] [Related]
3. Selective clonal expansion and microenvironmental permissiveness in tobacco carcinogenesis.
Rubin H
Oncogene; 2002 Oct; 21(48):7392-411. PubMed ID: 12379881
[TBL] [Abstract][Full Text] [Related]
4. Carcinogenicity assessment of selected nickel compounds.
Oller AR; Costa M; Oberdörster G
Toxicol Appl Pharmacol; 1997 Mar; 143(1):152-66. PubMed ID: 9073603
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenicity assessment of water-soluble nickel compounds.
Goodman JE; Prueitt RL; Dodge DG; Thakali S
Crit Rev Toxicol; 2009; 39(5):365-417. PubMed ID: 19514913
[TBL] [Abstract][Full Text] [Related]
6. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
DiGiovanni J; Rho O; Xian W; Beltrà n L
Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
[TBL] [Abstract][Full Text] [Related]
7. The differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the initiation-promotion protocol and by the complete carcinogenesis process.
Verma AK
Carcinog Compr Surv; 1982; 7():35-9. PubMed ID: 6802491
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and transformation potency of nickel compounds in BHK cells in vitro.
Hansen K; Stern RM
IARC Sci Publ; 1984; (53):193-200. PubMed ID: 6532980
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
10. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
Verma AK; Garcia CT; Ashendel CL; Boutwell RK
Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Nickel Sulfate Hexahydrate (CAS No. 10101-97-0) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Jul; 454():1-380. PubMed ID: 12587012
[TBL] [Abstract][Full Text] [Related]
13. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of chemical carcinogens.
Wattenberg LW
J Environ Pathol Toxicol; 1980 Mar; 3(4 Spec No):35-52. PubMed ID: 6993612
[TBL] [Abstract][Full Text] [Related]
15. Nickel (II) enhances benzo[a]pyrene diol epoxide-induced mutagenesis through inhibition of nucleotide excision repair in human cells: a possible mechanism for nickel (II)-induced carcinogenesis.
Hu W; Feng Z; Tang MS
Carcinogenesis; 2004 Mar; 25(3):455-62. PubMed ID: 14604891
[TBL] [Abstract][Full Text] [Related]
16. [Biochemical approaches to assessing the action of carcinogens on the human body].
Rubenchik BL
Vopr Onkol; 1983; 29(10):73-9. PubMed ID: 6356584
[No Abstract] [Full Text] [Related]
17. Activation and inactivation of carcinogens by microsomal monooxygenases: modification by benzoflavones and polycyclic aromatic hydrocarbons.
Wiebel FJ
Carcinog Compr Surv; 1980; 5():57-84. PubMed ID: 6993001
[No Abstract] [Full Text] [Related]
18. [Toxicity and carcinogenicity of nickel and its compounds. A review of the current status (author's transl)].
Raithel HJ; Schaller KH
Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 173(1-2):63-91. PubMed ID: 6455890
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics and human cancer.
Nebert DW
IARC Sci Publ; 1982; (39):365-80. PubMed ID: 7152614
[TBL] [Abstract][Full Text] [Related]
20. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
